Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06834607 · ClinicalTrials.gov registry record · NA

Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms

A NA study of Aortic Aneurysm and Complex Aortic Aneurysms, sponsored by Akhilesh Jain.

Recruiting
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT06834607: Recruiting NA study of Aortic Aneurysm and Complex Aortic Aneurysms, sponsored by Akhilesh Jain.

NCT06834607 is a NA study of Aortic Aneurysm and Complex Aortic Aneurysms that is actively recruiting participants, run by Akhilesh Jain. The registered enrollment target is 15 participants, below the 639-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06834607, a NA study of Aortic Aneurysm and Complex Aortic Aneurysms, is actively recruiting participants, sponsored by Akhilesh Jain.

RECRUITING
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in high-risk subjects considered to be high risk candidates for open surgical repair, have limited or no other options for on label treatment with an FDA approved device, and having appropriate anatomy.

Primary Outcome

The Primary Safety Endpoint is defined as the proportion of subjects who experience a Major Adverse Event (MAE) within 30 days of the index procedure. Major Adverse Events that will be recorded include the following: * All-cause mortality * Myocardial Infarction * Stroke * Renal Failure * Respiratory Failure * Paraplegia * Bowel Ischemia * Procedural Blood Loss (\> 1000cc)

Interventions

  • DEVICE Physician Modified Aortic Endograft repair for complex aortic aneurysm

Study Locations (1)

Connecticut

  • Hartford Hospital - Hartford

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2025-06-01
Est. Completion 2032-05-01
Phase NA
Akhilesh Jain

1 total trials

What NCT06834607 shows while recruiting

NCT06834607 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 639-participant average among 14 other Aortic Aneurysm trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Physician Modified Aortic Endograft repair for complex aortic aneurysm is the first listed.

NCT06834607 reports a single indexed study location in Connecticut.

Frequently Asked Questions

What is clinical trial NCT06834607 about?

NCT06834607 is a clinical study titled "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms". The primary objective of the clinical investigation "Physician Modified Endovascular Grafts for the Treatment of Elective, Symptomatic or Ruptured Complex Aortic Aneurysms" is to assess the use of the Physician-Modified Endovascular Grafts to repair juxtarenal aneurysms in high-risk subjects conside...

What is the current status of trial NCT06834607?

This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2025-06-01. Estimated completion is 2032-05-01.

What conditions does trial NCT06834607 study?

This clinical trial studies the following conditions: Aortic Aneurysm, Complex Aortic Aneurysms, Juxta Renal Abdominal Aortic Aneurysm Without Rupture.

What interventions are being tested in trial NCT06834607?

The interventions under investigation include: Physician Modified Aortic Endograft repair for complex aortic aneurysm (DEVICE).

Who is sponsoring clinical trial NCT06834607?

This trial is sponsored by Akhilesh Jain, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06834607 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06834607's enrollment target sits among peer trials

15 12th of 14 higher than 2 of 14 other Aortic Aneurysm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06834607, the US trial registry maintained by the National Library of Medicine. NCT06834607 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.